Jul 28, 2026 07:30AM
Jul 28, 2026 07:30AM
Jun 2, 2026 07:30AM
Jun 2, 2026 07:30AM
May 26, 2026 07:30AM
May 26, 2026 07:30AM
Apr 15, 2026 08:01AM Kazia Therapeutics names Dr. Sudha Rao as chief scientific officer
Apr 15, 2026 08:00AM
Apr 15, 2026 02:24AM
Apr 13, 2026 05:07PM
Apr 13, 2026 05:05PM
Jan 30, 2026 08:00AM
Jan 30, 2026 08:00AM
Jan 27, 2026 08:00AM Kazia Therapeutics reports responses in breast cancer trial
Jan 27, 2026 08:00AM
Dec 10, 2025 08:03AM
Dec 10, 2025 08:00AM
Nov 19, 2025 09:46AM
Nov 18, 2025 04:15PM
Nov 18, 2025 04:15PM
Oct 28, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Kazia Therapeutics (KZIA)
Oct 27, 2025 07:16AM
Oct 27, 2025 07:15AM
Oct 7, 2025 08:33AM
Oct 7, 2025 08:30AM
Oct 2, 2025 08:31AM
Oct 2, 2025 08:30AM
Oct 1, 2025 09:21AM Kazia Therapeutics Supports Australian MRFF-Funded Project Developing AI-Driven Sequential Therapy Strategy for DIPG/DMG
Sep 11, 2025 08:01AM
Sep 11, 2025 08:00AM
Jul 9, 2025 08:00AM
Jul 9, 2025 08:00AM
Jun 11, 2025 08:00AM
Jun 11, 2025 08:00AM
Jun 5, 2025 08:00AM Kazia Therapeutics Announces First Patient Dosed in Phase 1b Trial of Paxalisib in Advanced Breast Cancer
May 15, 2025 08:00AM
Mar 31, 2025 07:31AM
Mar 31, 2025 07:30AM
Feb 20, 2025 08:46AM
Feb 20, 2025 08:46AM
Jan 30, 2025 07:31AM
Jan 30, 2025 07:30AM Kazia Therapeutics announces the launch of a groundbreaking trial with paxalisib in combination with immunotherapy in women with advanced breast cancer
Jan 14, 2025 04:00PM
Jan 10, 2025 10:01AM
Jan 10, 2025 09:58AM
Dec 31, 2024 08:00AM
Dec 31, 2024 08:00AM
Dec 11, 2024 08:00AM
Nov 4, 2024 07:31AM Kazia Therapeutics (KZIA) Granted Type C Meeting with FDA to Discuss Potential Next Steps for Paxalisib
Nov 4, 2024 07:30AM

328,149 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All